Comparison |
| CLIA Classification |
CLIA Moderate Complexity | CLIA Non-Waived | | | |
| CLIA Classified |
CLIA Non-Waived | CLIA Non-Waived | | | |
| Container Type |
| | | Bottle | Bottle |
| Country of Origin |
United States | United States | Ireland | Ireland | Ireland |
| For Use With |
For FastPack IP System Blood Analyzer | For BD Viper Instrument | For Architect Ci8200 Analyzer | For Architect i1000 / i2000 Immunoassay Analyzers | For Architect Immunoassay Analyzers |
| Form |
| | Ready-to-Use Liquid | | |
| Number of Tests |
30 Tests | 1,152 Tests | 100 Tests | 100 Tests | 100 Tests |
| Product Dating |
| McKesson Acceptable Dating: we will ship >= 30 days | McKesson Acceptable Dating: we will ship >= 60 days | McKesson Acceptable Dating: we will ship >= 30 days | McKesson Acceptable Dating: we will ship >= 60 days |
| Sample Type |
Serum / Plasma Sample | Urine / Endocervical Swab / Vaginal Swab / Male Urethral Swab Sample | Serum Sample | Serum / Plasma Sample | Serum / Plasma Sample |
| Storage Requirements |
Requires Refrigeration | | Requires Refrigeration | Requires Refrigeration | Requires Refrigeration |
| Test Category |
Cancer Screening | Sexual Health | Cancer Screening | Thyroid Testing | Bone Metabolism |
| Test Method |
Paramagnetic Particle Immunoassay | Amplified DNA Assay | | Chemiluminescent Microparticle Immunoassay (CMIA) | Chemiluminescent Microparticle Immunoassay (CMIA) |
| Test Name |
Total Prostate-specific Antigen (PsA) | Chlamydia Trachomatis / Neisseria Gonorrhoeae (CT / NG) | Total Prostate-specific Antigen (PsA) | Free Thyroxine (FT4) | 25-hydroxyvitamin D (25-OH Vitamin D) |
| Test Type |
Antigen Detection | Infectious Disease | Antigen Detection | Thyroid / Metabolic Assay | Nutritional Assessment |
| Time to Results |
12 Minute Results | | | | |
| UNSPSC Code |
41116010 | 41116011 | 41116004 | 41116004 | 41116004 |
| Volume |
| 1,152 Tests | 1 Kit | R1: 6.6 mL, R2: 5.9 mL | R1: 6.6 mL, R2: 5.9 mL, R3: 10 mL |
| Application |
Immunoassay Reagent | Immunoassay Reagent | Immunoassay Reagent | Immunoassay Reagent | Immunoassay Reagent |
| Specialty |
Immunoassay | Immunoassay | Immunoassay | Immunoassay | Immunoassay |
| Features and Benefits |
- The FastPack® IP and FastPack® Total PSA Immunoassay is a paramagnetic particle immunoassay for the in vitro quantitative determination of prostate-specific antigen (PSA) in human serum and plasma as an aid in the management of patients with prostate cancer
- Each FastPack® IP carton contains 30 FastPacks
- Each FastPack® IP contains: Paramagnetic Particles, 150 µL; PSA Antibody Solution, 100 µL; Wash Buffer, 2.0 mL; Substrate, 140 µL
- Store at 2 – 8 °C
- Protect From Light
- Contents: (30) 150 µL FastPacks Containing Paramagnetic Particles, 100 µL PSA Antibody Solution, 2.0 mL Wash Buffer, 140 µL Substrate
- WARNING: Cancer and Reproductive Harm - www.P65Warnings.ca.gov
|
- Qualitative detection of Chlamydia trachomatis DNA in clinician-collected female endocervical and male urethral swab specimens, patient-collected vaginal swab specimens (in a clinical setting), and male and female urine specimens
|
- The ARCHITECT Total PSA assay is a Chemiluminescent Microparticle Immunoassay (CMIA) for the quantitative determination of total PSA (both free PSA and PSA complexed to alpha-1-antichymotrypsin) in human serum
|
- The ARCHITECT Free T4 (FT4) assay is a Chemiluminescent Microparticle Immunoassay (CMIA) for the quantitative determination of free thyroxine (Free T4) in human serum and plasma
|
- The ARCHITECT 25-OH Vitamin D assay is a chemiluminescent microparticle immunoassay (CMIA) for the quantitative determination of 25-hydroxyvitamin D (25-OH vitamin D) in human serum and plasma
- WARNING: Cancer and Reproductive Harm - www.P65Warnings.ca.gov
|
